Abstract: An electronic device powered by a solar panel and a rechargeable battery. The electronic device prevents unnecessary charging and discharging of the rechargeable battery by disconnecting the rechargeable battery when the rechargeable battery is fully charged. The electronic device detects and reports a defective rechargeable battery by powering the electronic device off of the solar panel. The electronic device detects and handles brownout conditions when powered by the solar panel by re-connecting the rechargeable battery.

Abstract: An electronic device powered by a solar panel and a rechargeable battery. The electronic device prevents draining of the rechargeable battery through the solar panel when the solar panel is unable to provide sufficient energy to power the electronic device. The electronic device prevents unnecessary charging and discharging of the rechargeable battery by disconnecting the rechargeable battery when the rechargeable battery is fully charged. The electronic device detects and reports a defective rechargeable battery by powering the electronic device off of the solar panel. The electronic device detects and handles brownout conditions when powered by the solar panel by re-connecting the rechargeable battery.

Abstract: Methods, systems, computer-readable media, devices, and apparatuses for synchronized mode transitions are presented. A first device configured to be worn at an ear includes a processor configured to, in a first contextual mode, receive a first mode change request from a second device to transition at a first time to a second contextual mode. The first mode change request is based on detection of a trigger condition. The processor is further configured to, at the first time, transition from the first contextual mode to the second contextual mode based on the first mode change request.

Abstract: The present invention relates to transgenic avians and the eggs produced therefrom wherein the eggs comprise a genetic modification that facilitates in ovo gender sorting and a genetic modification that increases a production trait in the eggs or the avians produced therefrom. The present invention also relates to methods of identifying the gender of eggs before hatching and methods of sorting the eggs based on gender before hatching.

Abstract: The present invention relates to methods of replicating viruses in vitro. In particular, the invention relates to a genetically modified population of cells, and/or a population of cells treated with an exogenous compound, wherein the cells are capable of producing more virus than cells lacking the genetic modification and/or lacking treatment with the exogenous compound. The invention also relates to methods of producing populations of such cells, as well as the use of the viruses obtained to prepare vaccine compositions.

Abstract: The present invention relates to methods of replicating viruses in vitro. In particular, the invention relates to a genetically modified population of cells, and/or a population of cells treated with an exogenous compound, wherein the cells are capable of producing more virus than cells lacking the genetic modification and/or lacking treatment with the exogenous compound. The invention also relates to methods of producing populations of such cells, as well as the use of the viruses obtained to prepare vaccine compositions.

Abstract: The present invention relates to modified avian eggs which can be used to produce increased levels of virus. The present invention also relates to methods of producing viruses in avian eggs of the invention, as well as the use of the viruses obtained to prepare vaccine compositions.

Abstract: The present invention relates to modified avian eggs which can be used to produce increased levels of virus. The present invention also relates to methods of producing viruses in avian eggs of the invention, as well as the use of the viruses obtained to prepare vaccine compositions.

Abstract: The present disclosure relates to methods of treating or preventing a viral infection in a subject. More specifically, the invention relates to methods of treating or preventing a Mononegavirales viral infection in a subject that comprises administering an effective amount of an angiotensin II signalling inhibitor.

Abstract: The present invention relates to methods of replicating viruses in vitro. In particular, the invention relates to a genetically modified population of cells, and/or a population of cells treated with an exogenous compound, wherein the cells are capable of producing more virus than cells lacking the genetic modification and/or lacking treatment with the exogenous compound. The invention also relates to methods of producing populations of such cells, as well as the use of the viruses obtained to prepare vaccine compositions.

Abstract: The present invention relates to transgenic avians and the eggs produced therefrom wherein the eggs comprise a genetic modification that facilitates in ovo gender sorting and a genetic modification that increases a production trait in the eggs or the avians produced therefrom. The present invention also relates to methods of identifying the gender of eggs before hatching and methods of sorting the eggs based on gender before hatching.

Abstract: The present invention relates to methods of replicating viruses in vitro. In particular, the invention relates to a genetically modified population of cells, and/or a population of cells treated with an exogenous compound, wherein the cells are capable of producing more virus than cells lacking the genetic modification and/or lacking treatment with the exogenous compound. The invention also relates to methods of producing populations of such cells, as well as the use of the viruses obtained to prepare vaccine compositions.

Abstract: The present invention relates to modified avian eggs which can be used to produce increased levels of virus. The present invention also relates to methods of producing viruses in avian eggs of the invention, as well as the use of the viruses obtained to prepare vaccine compositions.

Abstract: The present invention relates to methods of modulating an immune response and/or cytokine production in a subject, the method comprises administering to the subject a compound which modifies C6orf106 protein activity. The present invention also relates to compounds for modifying C6orf106 protein activity in a subject, as well as to screening methods for identifying such compounds.

Abstract: The present invention relates to methods of replicating viruses in vitro. In particular, the invention relates to a genetically modified population of cells, and/or a population of cells treated with an exogenous compound, wherein the cells are capable of producing more virus than cells lacking the genetic modification and/or lacking treatment with the exogenous compound. The invention also relates to methods of producing populations of such cells, as well as the use of the viruses obtained to prepare vaccine compositions.

Abstract: The present invention relates to modified avian eggs which can be used to produce increased levels of virus. The present invention also relates to methods of producing viruses in avian eggs of the invention, as well as the use of the viruses obtained to prepare vaccine compositions.

Abstract: The present invention relates to methods of detecting an increased likelihood of virus infection in a subject. In particular, the present invention relates to methods of detecting an increased likelihood of virus infection in a subject by detecting an altered level of at least one microRNA (miRNA), as well as methods of treating or preventing virus infection. The present invention also relates to nucleotide arrays, oligonucleotides and kits useful for the detection of miRNAs associated with an increased likelihood of virus infection in a subject.

Abstract: The present invention relates to methods of detecting an increased likelihood of virus infection in a subject. In particular, the present invention relates to methods of detecting an increased likelihood of virus infection in a subject by detecting an altered level of at least one microRNA (miRNA), as well as methods of treating or preventing virus infection. The present invention also relates to nucleotide arrays, oligonucleotides and kits useful for the detection of miRNAs associated with an increased likelihood of virus infection in a subject.

Abstract: A method of manufacturing a flow block for use as a T-Block, tree block, manifold block or valve block, the method including: machining a main bore in a body; forming an opening in the body in a side wall of the main bore; providing an insert including a first bore intersecting with a second bore and being in fluid communication with each other; forming a substantially curved surface on at least part of the intersection between the first bore and the second bore; and inserting the insert into the opening, such that the first bore is substantially aligned with the main bore in order to provide a fluid flow path between the main bore and the second bore.

Abstract: A foldable tricycle includes a first frame, a second frame movably coupled to the first frame, and a seat for supporting a rider, wherein the seat operates as an actuator for moving the first and second frames relative to each other. Additionally, a method of handling a foldable tricycle movable between a first position and a second position includes applying a force to the seat of the tricycle, wherein the applied force on the seat causes the tricycle to move from the first position to the second position.